Canada markets close in 5 hours 20 minutes

Khiron Life Sciences Corp. (KHRNF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 02:49PM EDT. Market open.

Khiron Life Sciences Corp.

500 Burrard Street
Suite 2300
Vancouver, BC
647 556-5750

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Alvaro Francisco TorresCo-Founder, CEO & Director199.2kN/A1979
Ms. Franziska KatterbachPresident of Khiron Europe281.45kN/AN/A
Mr. Swapan Kakumanu ACA, ACWA, CGACorporate Secretary43.79kN/A1970
Mr. Michael John O'Connor MAChief Financial OfficerN/AN/A1967
Mr. Manuel BuendiaVice President of OperationsN/AN/AN/A
Mr. Marco AlgortaCountry Manager of UruguayN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Corporate Governance

Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.